IR INFORMATION

2026.08.13

Summary of Consolidated Financial Results for the First Quarter of Fiscal Year Ending March 31, 2027 (Three Months Ended June 30, 2026)

2026.05.14

Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2026

2026.02.12

Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2026 (Nine Months Ended December 31, 2025)

2026.10.01

Notice Regarding the Status of Share Repurchase

2026.09.25

Notice of Disposal of Treasury Shares as Restricted Stock Compensation

2026.09.08

Start of Support for KENKO Investment for Health Outstanding Organization Certification Comprehensive Support Easy to Use for Even Midsize and Small Organizations

2026.06.24

Annual Securities Report（The 54th period ; April 1, 2025 to March 31, 2026）

2025.06.27

Annual Securities Report（The 53rd period ; April 1, 2024 to March 31, 2025）

2024.06.26

Annual Securities Report（The 52nd period ; April 1, 2023 to March 31, 2024）

2026.08.13

FY2027.3 First Quarter Financial Results Supplementary Materials

2026.06.15

FY2026.3 Financial Results Briefing

2025.12.10

FY2026.3 Financial Results Briefing for the 2nd Quarter

2026.06.26

Notice of Resolutions of the 54th Annual General Meeting of Shareholders

2026.06.04

Notice of the 54th Annual General Meeting of Shareholders

2025.06.26

Notice of Resolutions of the 53rd Annual General Meeting of Shareholders